SDMHF News Alert Sartorius Stedim Bio (SDMHF) 209.1500 02/15/2015
Post# of 64074
Posted On: 02/15/2015 1:02:03 PM
Sartorius Stedim Bio (SDMHF) 209.1500 $SDMHF
Research and Markets: Global Single-Use Bio-Processing Systems Market 2014-2018 With GE Healthcare, Merck & Co, Sartorius Stedim Biotech & ThermoFisher Scientific Dominating
Business Wire - Thu Jul 17, 5:36AM CDT
Research and Markets (http://www.researchandmarkets.com/research/twp8ts/global_singleuse) has announced the addition of the "Global Single-use Bio-processing Systems Market 2014-2018 with GE Healthcare, Merck & Co, Sartorius Stedim Biotech & ThermoFisher Scientific Dominating" report to their offering.
Global Single-use Bio-processing Systems Market 2014-2018 with GE Healthcare, Merck & Co, Sartorius Stedim Biotech & ThermoFisher Scientific Dominating
M2 - Thu Jul 17, 5:02AM CDT
Research and Markets (http://www.researchandmarkets.com/research/dkzwqv/global_singleuse) has announced the addition of the "Global Single-use Bio-processing Systems Market 2014-2018 with GE Healthcare, Merck & Co, Sartorius Stedim Biotech & ThermoFisher Scientific Dominating" report to their offering. The Global Single-use Bio-processing Systems market will grow at a CAGR of 38% to 2018 The report discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market. Owing to the growing potential of the Global Single-use Bio-processing Systems market, many bio-processing systems manufacturers collaborate to develop new platforms for the cultivation of cells or to develop new systems. For example, Sartorius's collaboration with Refine Technology LLC for the development of a robust platform for high-density cell cultivation. This platform will enable fast and easy connection of the alternating tangential flow system to Sartorius Stedim Biotech's field-proven single-use BIOSTAT bioreactors. Moreover, the partnership would enable the development of new designs of clinical analyzers and enable vendors to stay competitive in the market. This in turn could boost the growth of the Global Single-use Bio-processing Systems market. According to the report, the increasing demand for biopharmaceuticals is one of the major drivers in this market. The aging population in the US is expected to double and reach a total of 71 million by 2030. Cardiovascular diseases, Alzheimer's, and cancer are some of the most common diseases seen in the aged. Therefore, the steadily growing aging population increases the prevalence of these diseases, which in turn increases the demand for biopharmaceuticals. Further, the report states that the implementation of stringent regulations is one of the major challenges faced by the vendors in this market. Currently, the regulations for single-use bio-processing systems are not completely defined and documented, because the FDA has been quite liberal in not imposing more stringent regulations. However, the regulations are still uncertain owing to the limited usage of single-use bio-processing systems in commercial production. Key Vendors - GE Healthcare - Merck & Co Inc. - Sartorius Stedim Biotech SA - ThermoFisher Scientific Inc. Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - Market Segmentation by Applications - Geographical Segmentation - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/dk..._singleuse
MRK: 58.81 (-0.07)
Research and Markets: Global Single-Use Bio-Processing Systems Market 2014-2018 With GE Healthcare, Merck & Co, Sartorius Stedim Biotech & ThermoFisher Scientific Dominating
Business Wire - Thu Jul 17, 5:36AM CDT
Research and Markets (http://www.researchandmarkets.com/research/twp8ts/global_singleuse) has announced the addition of the "Global Single-use Bio-processing Systems Market 2014-2018 with GE Healthcare, Merck & Co, Sartorius Stedim Biotech & ThermoFisher Scientific Dominating" report to their offering.
Global Single-use Bio-processing Systems Market 2014-2018 with GE Healthcare, Merck & Co, Sartorius Stedim Biotech & ThermoFisher Scientific Dominating
M2 - Thu Jul 17, 5:02AM CDT
Research and Markets (http://www.researchandmarkets.com/research/dkzwqv/global_singleuse) has announced the addition of the "Global Single-use Bio-processing Systems Market 2014-2018 with GE Healthcare, Merck & Co, Sartorius Stedim Biotech & ThermoFisher Scientific Dominating" report to their offering. The Global Single-use Bio-processing Systems market will grow at a CAGR of 38% to 2018 The report discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market. Owing to the growing potential of the Global Single-use Bio-processing Systems market, many bio-processing systems manufacturers collaborate to develop new platforms for the cultivation of cells or to develop new systems. For example, Sartorius's collaboration with Refine Technology LLC for the development of a robust platform for high-density cell cultivation. This platform will enable fast and easy connection of the alternating tangential flow system to Sartorius Stedim Biotech's field-proven single-use BIOSTAT bioreactors. Moreover, the partnership would enable the development of new designs of clinical analyzers and enable vendors to stay competitive in the market. This in turn could boost the growth of the Global Single-use Bio-processing Systems market. According to the report, the increasing demand for biopharmaceuticals is one of the major drivers in this market. The aging population in the US is expected to double and reach a total of 71 million by 2030. Cardiovascular diseases, Alzheimer's, and cancer are some of the most common diseases seen in the aged. Therefore, the steadily growing aging population increases the prevalence of these diseases, which in turn increases the demand for biopharmaceuticals. Further, the report states that the implementation of stringent regulations is one of the major challenges faced by the vendors in this market. Currently, the regulations for single-use bio-processing systems are not completely defined and documented, because the FDA has been quite liberal in not imposing more stringent regulations. However, the regulations are still uncertain owing to the limited usage of single-use bio-processing systems in commercial production. Key Vendors - GE Healthcare - Merck & Co Inc. - Sartorius Stedim Biotech SA - ThermoFisher Scientific Inc. Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - Market Segmentation by Applications - Geographical Segmentation - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/dk..._singleuse
MRK: 58.81 (-0.07)
(0)
(0)Scroll down for more posts ▼